Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping.

J Thorac Oncol

Department of Tumor Biotherapy (Ward 5 of the Department of Oncology), West district of The First Affiliated Hospital of USTC, Division of life Sciences and Medicine, University of Science and Technology of China, Anhui Provincial Cancer Hospital, Hefei, Anhui Province, People's Republic of China. Electronic address:

Published: July 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.04.021DOI Listing

Publication Analysis

Top Keywords

acquired mechanism
4
mechanism crizotinib
4
crizotinib resistance
4
resistance nsclc
4
nsclc met
4
met exon
4
exon skipping
4
acquired
1
crizotinib
1
resistance
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!